Ferrari, D.; Clementi, N.; Criscuolo, E.; Ambrosi, A.; Corea, F.; Di Resta, C.; Tomaiuolo, R.; Mancini, N.; Locatelli, M.; Plebani, M.;
et al. Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine. Vaccines 2021, 9, 1357.
https://doi.org/10.3390/vaccines9111357
AMA Style
Ferrari D, Clementi N, Criscuolo E, Ambrosi A, Corea F, Di Resta C, Tomaiuolo R, Mancini N, Locatelli M, Plebani M,
et al. Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine. Vaccines. 2021; 9(11):1357.
https://doi.org/10.3390/vaccines9111357
Chicago/Turabian Style
Ferrari, Davide, Nicola Clementi, Elena Criscuolo, Alessandro Ambrosi, Francesca Corea, Chiara Di Resta, Rossella Tomaiuolo, Nicasio Mancini, Massimo Locatelli, Mario Plebani,
and et al. 2021. "Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine" Vaccines 9, no. 11: 1357.
https://doi.org/10.3390/vaccines9111357
APA Style
Ferrari, D., Clementi, N., Criscuolo, E., Ambrosi, A., Corea, F., Di Resta, C., Tomaiuolo, R., Mancini, N., Locatelli, M., Plebani, M., & Banfi, G.
(2021). Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine. Vaccines, 9(11), 1357.
https://doi.org/10.3390/vaccines9111357